Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.

We do this by channelling our efforts into identifying and sharing genuine thought leadership, executive insight and market intelligence. We disseminate this knowledge through an in depth bimonthly publication; Drugs & Dealers, through our web portal and critically through world class conferences and events that break the mould with innovative formats, networking and business development opportunities. We bring deals to life.

Biotech and Money New York and HealthEx New York are co-located events that aim to shine a light on New York's life science eco-system, helping promote NYC as a centre for life science excellence. It's where life science meets money, investors meet deal flow and industry promote strategic collaborations.

The congress provides genuine peer-to-peer knowledge sharing, networking and deal making opportunities between CxO level executives, and uncovers new ideas to move the industry forward. At its heart is the mission to promote NYC as a centre for life science excellence and help build linkages and business opportunities between East Coast life science companies and capital.

'Biotechs and the City' is the latest in a series of evening panel and networking events ran for members of the Biotech and Money Community. The October evening session is an invite only affair and will run from 6pm - 9.00pm on 8th October at a central London location to be announced.

The focus and topic of the panel and evening debate will be topical and will be released on 1st September.